Preclinical in vivo facility .: NR16-188/2017E-PDF
"The Preclinical in vivo Facility leverages the NRC’s expertise in cell and molecular biology, chemistry, nanotechnology, computer and imaging science to evaluate biologics and vaccines in a variety of disease and challenge models. Our expertise and state-of-the-art equipment enables our clients to validate their biologics and vaccine design approaches and obtain a clear picture of the preclinical safety and efficacy of their products"--P. [1].
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.848199&sl=0
| Department/Agency | National Research Council Canada. |
|---|---|
| Title | Preclinical in vivo facility . |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Installation préclinique in vivo. Caption title. "March 2018." Issued also in print format. |
| Publishing information | [Ottawa] : National Research Council Canada, 2018. |
| Description | [2] p. : col. ill. |
| ISBN | 9780660240954 |
| Catalogue number |
|
| Subject terms | Pharmaceutical biotechnology |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: